HBV

7 stories · following the connections

Business

Assembly Biosciences to Present at the Jefferies London Healthcare Conference

By Nasdaq OMXNov 8, 2017, 12:01 PM UTC

Business

Assembly Biosciences Announces Pricing of $60 Million Offering of Common Stock

By Nasdaq OMXNov 2, 2017, 4:41 AM UTC

Business

Assembly Biosciences Selects Next-Generation CpAM Candidate for Advancement into Clinical Development

By Nasdaq OMXSep 25, 2017, 11:00 AM UTC

Business

Assembly Biosciences Announces September Conference Participation

By Nasdaq OMXAug 31, 2017, 11:00 AM UTC

Business

ContraVir Pharmaceuticals to Present at BIO-Europe Spring 2017

By Nasdaq OMXMar 14, 2017, 10:00 AM UTC

Business

Assembly Biosciences to Present Data on ABI-H0731 at AASLD 2016 Liver Meeting

By Nasdaq OMXNov 11, 2016, 1:00 PM UTC

Business

Assembly Biosciences Initiates Phase 1 Clinical Program of ABI-H0731 for Treatment of Chronic Hepatitis B Virus Infection

By Nasdaq OMXNov 9, 2016, 12:05 PM UTC